Affordable Access

The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand.

Authors
Type
Published Article
Journal
Cancer immunity
Publication Date
Volume
4
Pages
9–9
Identifiers
PMID: 15384929
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments